To assess the transcriptomic signatures of CX3CR1+ CD8+ T cells in the tumor microenvironment, we analyzed the scRNA-seq dataset (GSE120575), where 48 tumor samples were collected at baseline and/or during ICI therapy from 32 patients (11). This evidence concerns the gene CX3CR1 and neoplasm.